blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1136481

EP1136481 - 1,2-Substituted 2,3-dihydro-1H-5,9-dioxacyclohepta[f]inden-7-ones and 7-substituted benzo[b][1,4]dioxepin-3-ones [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.09.2003
Database last updated on 26.06.2024
Most recent event   Tooltip02.02.2007Lapse of the patent in a contracting state
New state(s): DK		published on 07.03.2007  [2007/10]
Applicant(s)For all designated states
Givaudan SA
Chemin de la Parfumerie 5
1214 Vernier / CH
[2001/39]
Inventor(s)01 / Kraft, Philip
Kirchbachstrasse 4
8600 Dübendorf / CH
 [2001/39]
Representative(s)Schaad, Balass, Menzl & Partner AG
Bellerivestrasse 20
Postfach
8034 Zürich / CH
[N/P]
Former [2001/39]Patentanwälte Schaad, Balass, Menzl & Partner AG
Dufourstrasse 101 Postfach
8034 Zürich / CH
Application number, filing date01105987.010.03.2001
[2001/39]
Priority number, dateCH2000000055723.03.2000         Original published format: CH 5572000
[2001/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1136481
Date:26.09.2001
Language:EN
[2001/39]
Type: B1 Patent specification 
No.:EP1136481
Date:13.11.2002
Language:EN
[2002/46]
Search report(s)(Supplementary) European search report - dispatched on:EP02.08.2001
ClassificationIPC:C07D321/10, C11B9/00, A61K7/32
[2001/39]
CPC:
C11B9/0084 (EP,US); C07D321/10 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2002/24]
Former [2001/39]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:1,2-Substituierte 2,3-dihydro-1H-5,9-dioxacyclohepta(f)inden-7-one und 7-substituierte Benzo(b)[1,4]dioxepin-3-one[2001/39]
English:1,2-Substituted 2,3-dihydro-1H-5,9-dioxacyclohepta[f]inden-7-ones and 7-substituted benzo[b][1,4]dioxepin-3-ones[2001/39]
French:2,3-dihydro-1H-5,9-dioxacyclohepta(f)indene-7-ones 1,2-substitués et benzo(b)[1,4]dioxepines-3-ones 7 substituées[2001/39]
Examination procedure01.10.2001Examination requested  [2001/48]
10.01.2002Despatch of communication of intention to grant (Approval: No)
24.04.2002Despatch of communication of intention to grant (Approval: later approval)
13.06.2002Communication of intention to grant the patent
11.09.2002Fee for grant paid
11.09.2002Fee for publishing/printing paid
Opposition(s)14.08.2003No opposition filed within time limit [2003/45]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT13.11.2002
BE13.11.2002
FI13.11.2002
GR13.11.2002
TR13.11.2002
DK13.02.2003
PT13.02.2003
SE13.02.2003
CY10.03.2003
IE10.03.2003
LU10.03.2003
MC31.03.2003
[2007/10]
Former [2006/51]AT13.11.2002
BE13.11.2002
FI13.11.2002
GR13.11.2002
TR13.11.2002
PT13.02.2003
SE13.02.2003
CY10.03.2003
IE10.03.2003
LU10.03.2003
MC31.03.2003
Former [2005/02]AT13.11.2002
BE13.11.2002
FI13.11.2002
GR13.11.2002
PT13.02.2003
SE13.02.2003
CY10.03.2003
IE10.03.2003
LU10.03.2003
MC31.03.2003
Former [2004/44]AT13.11.2002
BE13.11.2002
FI13.11.2002
GR13.11.2002
PT13.02.2003
SE13.02.2003
CY10.03.2003
IE10.03.2003
LU10.03.2003
Former [2004/39]AT13.11.2002
BE13.11.2002
FI13.11.2002
GR13.11.2002
PT13.02.2003
SE13.02.2003
IE10.03.2003
LU10.03.2003
Former [2004/15]AT13.11.2002
BE13.11.2002
FI13.11.2002
GR13.11.2002
PT13.02.2003
SE13.02.2003
IE10.03.2003
Former [2003/51]AT13.11.2002
BE13.11.2002
FI13.11.2002
GR13.11.2002
PT13.02.2003
SE13.02.2003
Former [2003/43]AT13.11.2002
FI13.11.2002
GR13.11.2002
PT13.02.2003
SE13.02.2003
Former [2003/37]AT13.11.2002
GR13.11.2002
PT13.02.2003
SE13.02.2003
Former [2003/31]GR13.11.2002
PT13.02.2003
SE13.02.2003
Former [2003/29]PT13.02.2003
SE13.02.2003
Former [2003/19]SE13.02.2003
Documents cited:Search[A]US3517031  (BEEREBOO JOHN J, et al) [A] 1,2,6,7* column W *;
 [DA]EP0902024  (FIRMENICH & CIE [CH]);
 [A]US5990076  (GAUDIN JEAN-MARC [FR], et al) [A] 1,2,6,7 * column 1 - column 8 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.